Breaking News Instant updates and real-time market news.

CVS

CVS Health

$73.76

-0.73 (-0.98%)

11:25
10/15/18
10/15
11:25
10/15/18
11:25

Economic Club of Washington, D.C. to hold luncheon meeting

Luncheon Meeting with guest speaker CVS President & CEO, Larry Merlo, will be held in Washington, D.C. on October 15 at 12 pm.

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

CVS CVS Health
$73.76

-0.73 (-0.98%)

09/20/18
LEER
09/20/18
NO CHANGE
Target $250
LEER
Outperform
Cigna price target raised to $250 from $235 at Leerink
Leerink analyst Ana Gupte raised her price target on Outperform-rated Cigna (CI) to $250 from $235 following meetings with a panel of PBM and Specialty Rx specialists, which increased her bullishness on Cigna and Market Perform-rated Express Scripts (ESRX). In a research note to investors, Gupte says she also came away with raised confidence on the achiveability of the $4B annual drug cost savings from the Express Scripts switch by Anthem (ANTM) to IngenioRx in partnership with CVS (CVS). She adds that smaller independent PBMs still have niche opportunities with smaller regional third-party health plans, noting that Magellan Health (MGLN) is well positioned in this market, though loss of substantial business in Florida Seriously Mentally Ill is a headwind in Rx as well.
09/17/18
RBCM
09/17/18
NO CHANGE
Target $101
RBCM
Outperform
CVS Health price target raised to $101 from $90 at RBC Capital
RBC Capital analyst George Hill raised his price target on CVS Health (CVS) to $101 and kept his Outperform rating, citing the increased visibility of the company's merger with Aetna (AET) after its recent comments that it expects the deal to close in early Q4. The analyst also points to "de-risked" CVS investment thesis as it pertains to pharmacy benefit managers rebates and the much higher relative multiples for managed care companies, even though he warns that investors may still be spooked by any potential steps that the White House takes to drive prescription drug prices lower. Hill notes however that the latest government funding bill pulled the text that required drug companies to disclose prices in their ads, implying that the political will to change status quo may be limited.
08/27/18
RBCM
08/27/18
NO CHANGE
Target $94
RBCM
Outperform
Express Scripts price target raised to $94 from $90 at RBC Capital
RBC Capital analyst George Hills raised his price target on Express Scripts (ESRX) to $94 and kept his Outperform rating, citing the shareholders' "blessing" of the merger with Cigna (CI). The analyst notes that even though the regulators are yet to rule on the deal, he expects the merger to close by the end of the year and has a positive view of the "vertical consolidation thesis" for the company. Hill adds that the chance of a Department of Justice challenge to the merger is small in light of the seemingly clear path of the CVS (CVS) - Aetna (AET) merger, but if regulators do seek concessions, he expects the necessary divestitures to be small.
08/23/18
08/23/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. ROSENBLATT BOOSTS AMD PRICE TARGET TO STREET HIGH: Rosenblatt analyst Hans Mosesmann raised his price target for AMD (AMD) shares to $30 from $27. Mosesmann's new price target represents the high among Wall Street sell-side analysts. Following the meetings, Mosesmann has renewed conviction in AMD's multi-year double digit growth profile. Further, he's impressed by the analysis investors are doing in the name after years of disregard. AMD is up 4.1% in late morning trading. CANTOR CUTS AETNA TO NEUTRAL: Cantor Fitzgerald analyst Steven Halper downgraded Aetna (AET) to Neutral from Overweight with a price target of $202. The stock now trades at just a 4.6% discount to the implied CVS Health (CVS) acquisition value of about $207 per share, Halper said. He believes the narrowed deal spread reflects an increased likelihood of regulatory approval. Halper cites limited potential upside for his downgrade of Aetna to Neutral. NIELSEN UPGRADED TO NEUTRAL AT GOLDMAN: Goldman Sachs analyst George Tong upgraded Nielsen Holdings (NLSN) to Neutral and raised his price target for the shares to $25 from $20. With activist Elliott Management pushing for a sale and increased deal activity in the Information Services sector, Tong sees increased likelihood of Nielsen being involved in a transaction. His upgrade to Neutral and price target increase come after the analyst incorporated a potential takeover into his model. Nielsen is up 3.3% in late morning trading. IMPERIAL SEES SUBSCRIBER UPSIDE FOR NETFLIX: Imperial Capital analyst David Miller believes Netflix's (NFLX) experiment with ending billing through Apple's (AAPL) app store in 33 countries outside the U.S. likely implies upside to its Q3 international subscriber guidance. The analyst said he has a tough time believing that Netflix would "experiment" with billing infrastructure mid-quarter if it did not believe that its international subscriber levels were trending ahead of guidance. As such, Miller raised his Q3 international subscriber estimate to 4.46M from 4.35M. He kept an Outperform rating on Netflix with a $494 price target. TARGET GETS UPGRADE AND DOWNGRADE: Target (TGT) was upgraded to Outperform from Market Perform at Telsey Advisory, and downgraded to Peer Perform from Outperform at Wolfe Research.

TODAY'S FREE FLY STORIES

VZ

Verizon

$60.11

-0.44 (-0.73%)

, CMCSA

Comcast

$45.42

-0.25 (-0.55%)

10:21
10/16/19
10/16
10:21
10/16/19
10:21
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

VZ

Verizon

$60.11

-0.44 (-0.73%)

CMCSA

Comcast

$45.42

-0.25 (-0.55%)

T

AT&T

$37.95

0.045 (0.12%)

INOV

Inovalon

$15.19

0.145 (0.96%)

ASMB

Assembly Biosciences

$10.95

1.65 (17.74%)

CDXC

ChromaDex

$3.19

0.19 (6.33%)

AXSM

Axsome Therapeutics

$20.68

0.03 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 19

    Nov

ADBE

Adobe

$267.83

-11.57 (-4.14%)

, AYI

Acuity Brands

$122.30

-2.51 (-2.01%)

10:20
10/16/19
10/16
10:20
10/16/19
10:20
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

ADBE

Adobe

$267.83

-11.57 (-4.14%)

AYI

Acuity Brands

$122.30

-2.51 (-2.01%)

COST

Costco

$296.18

-2.24 (-0.75%)

NOW

ServiceNow

$251.66

-22.94 (-8.35%)

XOG

Extraction Oil & Gas

$2.47

-0.18 (-6.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 27

    Oct

  • 29

    Oct

  • 04

    Nov

  • 07

    Nov

  • 12

    Dec

JNJ

Johnson & Johnson

$135.77

2.93 (2.21%)

, FMC

FMC Corporation

$84.39

1.33 (1.60%)

10:20
10/16/19
10/16
10:20
10/16/19
10:20
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

JNJ

Johnson & Johnson

$135.77

2.93 (2.21%)

FMC

FMC Corporation

$84.39

1.33 (1.60%)

PSTG

Pure Storage

$17.92

0.27 (1.53%)

PDFS

PDF Solutions

$14.29

1.08 (8.18%)

BLDR

Builders FirstSource

$22.13

0.59 (2.74%)

BMCH

BMC Stock Holdings

$26.94

0.79 (3.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 01

    Nov

  • 05

    Nov

  • 13

    Nov

  • 14

    Nov

  • 12

    Dec

  • 17

    Dec

WE

We Company

$0.00

(0.00%)

, SFTBF

SoftBank

$0.00

(0.00%)

10:20
10/16/19
10/16
10:20
10/16/19
10:20
Periodicals
SoftBank to give We Company $5B financing, won't take majority stake, NAR says »

SoftBank Group (SFTBF)…

WE

We Company

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRLBF

Cresco Labs

$0.00

(0.00%)

10:18
10/16/19
10/16
10:18
10/16/19
10:18
Hot Stocks
Cresco Labs receives adult-use approval for all five Illinois dispensaries »

Cresco Labs announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
10/16/19
10/16
10:17
10/16/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
10/16/19
10/16
10:16
10/16/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WORK

Slack Technologies

$22.90

-1.84 (-7.44%)

10:15
10/16/19
10/16
10:15
10/16/19
10:15
Options
Slack put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
10/16/19
10/16
10:15
10/16/19
10:15
General news
U.S. NAHB housing market index jumped 3 points to 71 in October »

U.S. NAHB housing market…

10:15
10/16/19
10/16
10:15
10/16/19
10:15
General news
U.S. business inventories were unchanged in August, with sales up 0.2% »

U.S. business inventories…

MKGAF

Merck KGaA

$0.00

(0.00%)

10:13
10/16/19
10/16
10:13
10/16/19
10:13
Conference/Events
Merck KGaA participates in a conference call with JPMorgan »

European Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:10
10/16/19
10/16
10:10
10/16/19
10:10
General news
FX Action: The dollar »

FX Action: The dollar was…

10:07
10/16/19
10/16
10:07
10/16/19
10:07
General news
Atlanta Fed Business Inflation Expectations Bus Infl Exp % Yr/Yr data reported »

October Atlanta Fed…

APLS

Apellis

$28.15

1.71 (6.47%)

10:06
10/16/19
10/16
10:06
10/16/19
10:06
Conference/Events
Apellis participates in a conference call with JPMorgan »

SMid Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

AEP

American Electric

$91.59

-0.14 (-0.15%)

10:06
10/16/19
10/16
10:06
10/16/19
10:06
Hot Stocks
American Electric names Julius Cox SVP, chief human resources officer »

American Electric Power…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 10

    Nov

  • 12

    Nov

AEO

American Eagle

$15.07

0.115 (0.77%)

10:05
10/16/19
10/16
10:05
10/16/19
10:05
Hot Stocks
American Eagle to hire roughly 10,000 part-time seasonal brand ambassadors »

American Eagle Outfitters…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:02
10/16/19
10/16
10:02
10/16/19
10:02
General news
Business Inventories data reported »

August Business…

10:02
10/16/19
10/16
10:02
10/16/19
10:02
General news
Housing Market Index data reported »

October Housing Market…

VRRM

Verra Mobility

$13.89

-0.14 (-1.00%)

10:01
10/16/19
10/16
10:01
10/16/19
10:01
Hot Stocks
Verra Mobility to acquire Pagatelia, terms not disclosed »

Verra Mobility announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 07

    Nov

  • 13

    Nov

  • 14

    Nov

TIGR

UP Fintech

$3.90

-0.16 (-3.94%)

10:00
10/16/19
10/16
10:00
10/16/19
10:00
Periodicals
UP Fintech accused by GeoInvesting of 'illegal money laundering scheme' »

GeoInvesting has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MERC

Mercer

$11.20

0.03 (0.27%)

10:00
10/16/19
10/16
10:00
10/16/19
10:00
Conference/Events
Mercer participates in a conference call with JPMorgan »

LatAm Pulp & Paper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AYX

Alteryx

$104.75

-7.58 (-6.75%)

10:00
10/16/19
10/16
10:00
10/16/19
10:00
Hot Stocks
Alteryx falls -6.8% »

Alteryx is down -6.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 06

    Nov

CPS

Cooper-Standard

$33.60

-2.77 (-7.62%)

10:00
10/16/19
10/16
10:00
10/16/19
10:00
Hot Stocks
Cooper-Standard falls -7.7% »

Cooper-Standard is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVD

American Vanguard

$13.50

-1.76 (-11.53%)

10:00
10/16/19
10/16
10:00
10/16/19
10:00
Hot Stocks
American Vanguard falls -12.2% »

American Vanguard is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 19

    Nov

  • 20

    Nov

OMI

Owens & Minor

$6.85

0.42 (6.53%)

10:00
10/16/19
10/16
10:00
10/16/19
10:00
Hot Stocks
Owens & Minor rises 6.2% »

Owens & Minor is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.